Previous 10 | Next 10 |
Acurx Pharmaceuticals Joins the Antimicrobials Working Group PR Newswire WASHINGTON , Aug. 5, 2021 /PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (Acurx) to its coalition of c...
DUBLIN, Ireland, July 22, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it will report its second quarter fi...
Nabriva Therapeutics plc (NASDAQ:NBRV) traded today at a new 52-week low of $1.10. Approximately 12.1 million shares have changed hands today, as compared to an average 30-day volume of 1.8 million shares. In the past 52 weeks, shares of Nabriva Therapeutics plc have traded between the c...
Nabriva Therapeutics plc (NASDAQ:NBRV) traded at a new 52-week low today of $1.13. So far today approximately 12.1 million shares have been exchanged, as compared to an average 30-day volume of 7.4 million shares. Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. Na...
Nabriva Therapeutics plc (NASDAQ:NBRV) traded today at a new 52-week low of $1.20. Approximately 12.1 million shares have changed hands today, as compared to an average 30-day volume of 7.3 million shares. Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. Nabriva is...
Nabriva Therapeutics plc (NASDAQ:NBRV) traded at a new 52-week low today of $1.25. This new low was reached on above average trading volume as 12.1 million shares traded hands, while the average 30-day volume is approximately 7.3 million shares. There is potential upside of 82.5% for sha...
Nabriva Therapeutics plc (NASDAQ:NBRV) traded at a new 52-week low today of $1.28. Approximately 12.1 million shares have changed hands today, as compared to an average 30-day volume of 7.1 million shares. Nabriva Therapeutics PLC is a clinical stage biopharmaceutical company. Nabriva is...
Crestone Joins Antimicrobials Working Group PR Newswire WASHINGTON , June 8, 2021 /PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of Crestone, Inc. (Crestone) to its coalition of companies with the mission to combat drug r...
- Principal Repayments Delayed At Least Until January 1, 2022 - Repayment Delay and Recent ATM Activity Extends Cash Runway Substantially Through the First Quarter of 2022 DUBLIN, Ireland and FORT WASHINGTON, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc ...
DUBLIN, Ireland and FORT WASHINGTON, Pa., June 02, 2021 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced today that Dr. Ma...
News, Short Squeeze, Breakout and More Instantly...
Nabriva Therapeutics plc Company Name:
NBRV Stock Symbol:
NASDAQ Market:
-Company To Focus on Preserving Cash to Fund Orderly Wind Down of Operations- -Company To Continue Work With Torreya Capital On Asset Monetization- DUBLIN, Ireland, Jan. 06, 2023 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV) today announced that, after an assessment ...
- PK Data and Safety Profile Consistent with Previous Studies in Healthy Subjects – - Results Support Potential Utility of Lefamulin in Patients with Cystic Fibrosis - DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Na...
- Shifted Focus to SIVEXTRO to Enable Cost Cutting - - Cash Runway Extended into Q1 2023 - - Q3 2022 Total Revenue of $9.2 Million - - Engaged Torreya Capital As Strategic Advisor - - Conference call today at 4:30 p.m. Eastern Time - DUBLIN, Ireland, ...